{"id":"ribavirin-loading-dose-given","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Hemolytic anemia"},{"rate":null,"effect":"Teratogenicity/embryocidal effects"},{"rate":"20-40","effect":"Fatigue"},{"rate":"10-20","effect":"Dyspnea"},{"rate":"15-30","effect":"Headache"},{"rate":"10-20","effect":"Insomnia"},{"rate":"10-25","effect":"Nausea"},{"rate":"5-15","effect":"Rash"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ribavirin is converted intracellularly to its active triphosphate form, which inhibits inosine monophosphate dehydrogenase (IMPDH), depleting guanosine nucleotides needed for viral RNA synthesis. It also directly inhibits viral RNA-dependent RNA polymerase and can cause lethal mutagenesis in viral genomes. The 'loading' dose refers to an initial higher dose regimen used to rapidly achieve therapeutic concentrations.","oneSentence":"Ribavirin is a nucleoside analog that inhibits viral RNA synthesis by interfering with guanosine triphosphate pools and viral polymerase activity.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:32:05.217Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis C (in combination with interferon-alpha or direct-acting antivirals)"},{"name":"Severe respiratory syncytial virus (RSV) infection"},{"name":"Lassa fever and other hemorrhagic fevers"}]},"trialDetails":[{"nctId":"NCT02109744","phase":"PHASE1, PHASE2","title":"Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2014-03","conditions":"Acute Myelogenous Leukemia","enrollment":27},{"nctId":"NCT01226771","phase":"PHASE3","title":"Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2010-09","conditions":"Hepatitis C","enrollment":105}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"19940926","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19930304","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19930401","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19890313","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19851231","type":"ORIG","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19890328","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19880915","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19890602","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19860827","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19980326","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19900606","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"20140627","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19940310","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19890313","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19930712","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19920923","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19870409","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19930205","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"20000228","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"19860827","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"20160106","type":"SUPPL","sponsor":"BAUSCH","applicationNumber":"NDA018859"},{"date":"20161006","type":"ORIG","sponsor":"NAVINTA LLC","applicationNumber":"ANDA207366"},{"date":"20230419","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079111"},{"date":"20160106","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079111"},{"date":"20160106","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079111"},{"date":"20090917","type":"ORIG","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079111"},{"date":"20160106","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079111"},{"date":"20110316","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079111"},{"date":"20140519","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20230322","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20210414","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20160111","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20140519","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20090917","type":"ORIG","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20140519","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20210414","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20111116","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20210414","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"},{"date":"20100402","type":"SUPPL","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA079117"}],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ribavirin \"loading\" dose given","genericName":"Ribavirin \"loading\" dose given","companyName":"Göteborg University","companyId":"g-teborg-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ribavirin is a nucleoside analog that inhibits viral RNA synthesis by interfering with guanosine triphosphate pools and viral polymerase activity. Used for Chronic hepatitis C (in combination with interferon-alpha or direct-acting antivirals), Severe respiratory syncytial virus (RSV) infection, Lassa fever and other hemorrhagic fevers.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}